Clinical Trial Update: Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. [Phase 3]

View source ↗

Summary

A Phase 3 study sponsored by Pfizer evaluates the safety and efficacy of pregabalin in patients with painful diabetic neuropathy; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED